The Clinical and Translational Science Award (CTSA) program’s Trial Innovation Network (TIN) offers support for efficacy to effectiveness (E2E) trials, or trials where a successful efficacy study transitions seamlessly into an effectiveness trial. Studies like these are important because they address safety gaps, streamline the trial process, and offer an opportunity to better understand how a treatment will work in real-world clinical settings.
Learn how to boost your trial design at the two-day E2E Design Lab workshop March 7-8 in Boston, MA, offered by CTSA’s Massachusetts Institute of Technology (MIT) NEWDIGS program in collaboration with the JHU-Tufts Trial Innovation Center. The interactive event will dive into the process of planning a Phase 2 or Phase 3 E2E multi-center trial to help you improve your research and study design.
Source: Trial Innovation Network